Home HealthTopics Health Centers Reference Library Research
Join us on Facebook Join us on Facebook Share on Facebook

Asthma

Atrovent Debate

02/21/2001

Question:

Can you explain to me the debate of using Atrovent for pulmonary diseases? I know it is a generally localized Muscarinic antagonist. Is the debate dealing with the decreased mucous secretion and dilated bronchioles causing more exposure to allergens?

Answer:

I`m not aware of any debate. Atrovent is a bronchodilator with anticholinergic activity. Several studies have shown excellent action on patients with COPD where it is often considered first line therapy. For asthma it also a bronchodilator but is mainly used as adjunctive therapy.

For more information:

Go to the Asthma health topic, where you can:

Response by:

Mitchell C Rashkin, MD Mitchell C Rashkin, MD
Professor of Medicine
College of Medicine
University of Cincinnati